Imaging shows anatomical patterns, but it may not establish what is causing an abnormality. Microscopic examination allows pathologists to evaluate tissue architecture and cellular changes directly, while molecular analysis can add information about disease-associated features. This combination helps distinguish processes such as inflammation, infection, abnormal cell growth, and cancer when clinical findings remain inconclusive.
Microscopy examines the structure and appearance of cells within preserved tissue, revealing patterns that support disease recognition. Molecular testing evaluates biological features that may not be visible under the microscope. Used together, these approaches can strengthen diagnostic interpretation, support tumor classification, and provide information relevant to selecting treatment or estimating prognosis.
Immunohistochemistry uses tissue analysis to assess selected biological markers, adding diagnostic detail beyond ordinary structural examination. Genomic testing examines molecular characteristics that can further distinguish disease subtypes or identify clinically relevant features. These methods extend the value of a biopsy from identifying abnormal tissue to supporting more precise diagnosis and personalized medicine.
The collection approach depends on the tissue site and the information clinicians need. A needle may obtain tissue through a focused sampling procedure, an endoscope may access tissue through an internal passage, and a surgical incision may be used when broader or more direct access is required. The selected approach determines how tissue reaches pathology for examination.
After collection, the sample is preserved so its features remain suitable for examination. Pathology processing then involves sectioning the tissue into thin portions and applying stains that make relevant structures easier to evaluate microscopically. Depending on the clinical question, the prepared material may also undergo immunohistochemistry or genomic testing, producing complementary structural and molecular findings.
Biopsy findings become especially valuable when symptoms or imaging do not provide a definitive diagnosis. Results can identify inflammation, infection, abnormal cell growth, or cancer, while additional analysis may classify a tumor more precisely. These findings can influence treatment selection and prognosis, making the procedure relevant not only to diagnosis but also to subsequent clinical planning.